Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan.
Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan.
复制标题
DOI:
10.1111/j.1474-9726.2011.00689.x
复制
发表时间:
2011-06
期刊:
影响因子:
7.8
通讯作者:
Yashin AI
中科院分区:
文献类型:
--
作者:
Kulminski AM;Culminskaya I;Ukraintseva SV;Arbeev KG;Arbeeva L;Wu D;Akushevich I;Land KC;Yashin AI
Progress in unraveling the genetic origins of healthy aging is tempered, in part, by a lack of replication of effects, which is often considered a signature of false positive findings. We convincingly demonstrate that the lack of genetic effects on an aging-related trait can be due to trade-offs in the gene action. We focus on the well-studied apolipoproetin E (APOE) e2/3/4 polymorphism and on lifespan and ages at onset of cardiovascular diseases (CVD) and cancer, using data on 3,924 participants of the Framingham Heart Study Offspring cohort. Kaplan-Meier estimates show that the e4 allele carriers live shorter lives than the non-e4 allele carriers (log rank=0.016). The adverse effect was attributed to the poor survival of the e4 homozygotes, whereas the effect of the common e3/4 genotype was insignificant. The e3/4 genotype, however, was antagonistically associated with onsets of those diseases predisposing to an earlier onset of CVD and a later onset of cancer compared to the non-e4 allele genotypes. This trade-off explains the lack of a significant effect of the e3/4 genotype on survival; adjustment for it in the Cox regression model makes the detrimental effect of the e4 allele highly significant (p=0.002). This trade-off is likely caused by the lipid-metabolism-related (for CVD) and non-related (for cancer) mechanisms. An evolutionary rationale suggests that genetic trade-offs should not be an exception in studies of aging-related traits. Deeper insights into biological mechanisms mediating gene action are critical for understanding the genetic regulation of a healthy lifespan and for personalizing medical care.
登录
查看更多内容
影响因子:
4
作者:
Greer, Eric L.;Brunet, Anne
通讯作者:
Brunet, Anne
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
9.8
作者:
Gorlov, Ivan P.;Gorlova, Olga Y.;Amos, Christopher I.
通讯作者:
Amos, Christopher I.
影响因子:
3.9
作者:
Bonomini, Francesca;Filippini, Francesca;Rezzani, Rita
通讯作者:
Rezzani, Rita
DOI:
10.1073/pnas.0809594106
发表时间:
2009-02-24
影响因子:
11.1
作者:
Flachsbart, Friederike;Caliebeb, Amke;Nebel, Almut
通讯作者:
Nebel, Almut